Inhibitory effects of bortezomib in a subcutaneous tumor model of H22 mouse hepatocarcinoma cells.

CONCLUSION: Bortezomib effectively inhibited the growth of H22 xenografts without affecting the mouse weight. The anti-tumor effects of bortezomib is associated with its stimulation on tumor cell apoptosis.
PMID: 30914235 [PubMed - as supplied by publisher]

Source: Pathology, Research and Practice - March 17, 2019 Category: Pathology Authors: Zhu M Tags: Pathol Res Pract Source Type: research